[PDF] Top 20 Construcción Social de Espacio Público en Barrios Populares de Bogotá
Has 10000 "Construcción Social de Espacio Público en Barrios Populares de Bogotá" found on our website. Below are the top 20 most common "Construcción Social de Espacio Público en Barrios Populares de Bogotá".
Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation
... scores from baseline to T15, T30, and T60, respectively, − ...in pain intensity scores from baseline to T30 are shown as a waterfall graph in Figure ...(91.4%) patients had achieved a ... See full document
51
Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study
... In patients who had previously received weak opioids, the starting OXN-PR dose was determined using conventional conversion tables for opioid ...All patients received their first OXN-PR ... See full document
26
Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients
... All patients provided written informed consent for the collection and analysis of their anonymous demographic and clinical ...inclusion, patients had to meet the following criteria: age 70 years; suffering ... See full document
15
An Investigation into the Role of Insulin in Pain Threshold.
... glucagon release from the perfused dog pancreas and in high concentrations increases the circulating levels of insulin without change in ...of pain has also been reported by few ...insulin ... See full document
1
<p>Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines</p>
... of patients initiating statins, ezetimibe, or at very high cardiovascular ...ASCVD risk. Given the release of the updated 2018 cholesterol guidelines, future research is warranted to ... See full document
12
Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial
... included dose, duration of use, and administration frequency of analgesic rescue medi- cation (immediate-release oxycodone) and laxative res- cue medication (MgO) used during the study; change in ... See full document
89
Relative frequency and risk factors for long-term opioid therapy following surgery and trauma among adults: a systematic review protocol
... time from the pooled effect size es- timation, (2) we will repeat the pooled effect size estimation by including only studies with low risk of bias, and (3) as we anticipate that confounding ... See full document
18
Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids
... alternative opioid treatments in a randomized 1:1:1 ratio (block size nine) after completion of the baseline evaluation by the physician and confirmation of a general treatment indication for a WHO ... See full document
7
Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice
... the risk of bias, as physicians were able to address effectiveness and tolerability problems with concomitant treatment options chosen in the knowledge of which opioid analgesic the patient was ... See full document
7
Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone
... improvement from “very severe” at the start of treatment to “mild” or “moderate” on average at the end of the double-blind ...of patients were considered ...of oxycodone–naloxone PR was ... See full document
12
Emerging therapies for acute myeloid leukemia
... same drugs administered conventionally ...AML patients at age 60–75 years, who were fit for intensive chemotherapy ...all patients were ...of patients with secondary AML (sAML; ... See full document
29
Tapentadol extended release in the management of peripheral diabetic neuropathic pain
... in pain indices and quality of life measures of patients treated with ...in patients who have previously failed treatment with more conventional opioid ...therapy. Chronic ... See full document
12
Tapentadol extended-release for treatment of chronic pain: a review
... for pain in patients with chronic osteoarthritis, low back pain, and pain associated with diabetic peripheral ...of chronic pain conditions, including ... See full document
120
Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature
... of oxycodone ER. One or more AEs were experienced by 678 patients (82%), with the most common side effects related to opioids (constipation, nausea, and somnolence), 173 patients (21%) discontinued ... See full document
8
A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain
... in patients with moderate/severe chronic cancer ...eligible patients stopped their pre- study opioid and laxative medication and were ran- domized (on Day 1/Visit 2) to switch directly to ... See full document
8
Patient considerations in the use of tapentadol for moderate to severe pain
... and chronic pain can increase morbidity, impair quality of life and prolong ...surgical patients report moderate to severe uncontrolled postoperative ...potent opioid agonists can lead to ... See full document
8
<p>Tapentadol: an overview of the safety profile</p>
... other drugs by Raffa and Pergolizzi; they state that the categorization of all analgesics that have any component of opioid mechanism of action into the same class is anachronistic and ...fewer ... See full document
21
Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study
... starting dose of OXN-PR at T0 was 5/2.5 mg of naloxone twice a ...daily dose could be modified up to a maximum of 10/5 mg twice a day in case of insufficient ...control pain, all ... See full document
8
Dependence to legally prescribed opioid analgesics in a university hospital in Medellin-Colombia: an observational study
... and/or high doses of tramadol may be one important risk factor of abuse even for those with no prior drug abuse ...mu opioid re- ceptor agonist and also possesses catecholamine re- uptake inhibitor ... See full document
5
Tapentadol extended release for the management of chronic neck pain
... to patients with cervical diseases. Our results showed that patients can experience a significant increase in neck ROM after 3 months of treatment with tapentadol ...neuropathic pain in ... See full document
10
Related subjects